Priority 1 from the Myeloma (Canada) PSP
| UNCERTAINTY: How can we cure myeloma? (JLA PSP Priority 1) | |
|---|---|
| Overall ranking | 1 |
| JLA question ID | 0113/1 |
| Explanatory note | Ultimately, myeloma patients, caregivers, and healthcare providers would like to see a cure for multiple myeloma. While current treatment options have led to prolonged remissions and improved quality of life, patients must continue with treatments and live a "tiring existence" with myeloma. Many look forward to a day when there will be a cure for myeloma. In the meantime, they would like to be updated of progress towards this goal. |
| Evidence |
No evidence identified |
| Health Research Classification System category | Cancer and neoplasms |
| Extra information provided by this PSP | |
|---|---|
| Original uncertainty examples | What is a cure for Myeloma? ~ Can myeloma be cured? ~ Why is there no cure yet? ~ Of couse the 'holy grail' of research would be to get an answer on a cure for this disease. ~ Of course a cure ultimately. Understanding the disease better through historical data may help lead to this. |
| Submitted by | Please see the PSP Engagement Summary on the JLA website |
| PSP information | |
|---|---|
| PSP unique ID | 0113 |
| PSP name | Myeloma (Canada) |
| Total number of uncertainties identified by this PSP. | 59 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website) |
| Date of priority setting workshop | 28 April 2021 |